OM
MGNX icon

Opaleye Management’s MacroGenics MGNX Stock Holding History

Opaleye Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-208,300
Closed -$614K – 49
2022
Q2 		$614K Sell
208,300
-168,100
-45% -$884K 0.28% 39
2022
Q1 		$3.32M Sell
376,400
-85,600
-19% -$945K 1.03% 26
2021
Q4 		$7.42M Hold
462,000
– – 1.57% 24
2021
Q3 		$9.67M Sell
462,000
-116,150
-20% -$2.8M 1.81% 18
2021
Q2 		$15.5M Sell
578,150
-88,050
-13% -$2.58M 2.58% 12
2021
Q1 		$21.2M Buy
666,200
+295,600
+80% +$7.18M 3.12% 7
2020
Q4 		$8.47M Sell
370,600
-156,400
-30% -$3.6M 1.11% 26
2020
Q3 		$13.3M Buy
527,000
+26,000
+5% +$710K 2.6% 13
2020
Q2 		$14M Buy
501,000
+78,700
+19% +$1.37M 2.83% 12
2020
Q1 		$2.46M Buy
422,300
+221,800
+111% +$2.01M 0.65% 33
2019
Q4 		$2.18M Buy
+200,500
New +$1.98M 0.43% 44
2019
Q1 		– Sell
-150,000
Closed -$1.91M – 56
2018
Q4 		$1.91M Buy
+150,000
New +$2.52M 0.71% 35
2017
Q1 		– Sell
-170,000
Closed -$3.48M – 46
2016
Q4 		$3.48M Buy
170,000
+25,000
+17% +$629K 2.05% 19
2016
Q3 		$4.34M Buy
145,000
+33,000
+29% +$982K 2.27% 16
2016
Q2 		$3.02M Buy
+112,000
New +$2.53M 2.02% 17
2016
Q1 		– Sell
-35,000
Closed -$1.08M – 56
2015
Q4 		$1.08M Buy
+35,000
New +$1.06M 0.45% 47
2015
Q3 		– Sell
-90,000
Closed -$3.42M – 51
2015
Q2 		$3.42M Buy
90,000
+40,000
+80% +$1.31M 1.36% 27
2015
Q1 		$1.57M Buy
+50,000
New +$1.69M 0.73% 32
2014
Q2 		– Sell
-30,000
Closed -$838K – 31
2014
Q1 		$838K Buy
+30,000
New +$1.06M 0.62% 27

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Opaleye Management's MGNX Position: Q3 2022 in Review

Opaleye Management sold out of MacroGenics (MGNX) in Q3 2022, closing a stake of 208,300 shares — an estimated $614K sold.

Opaleye Management first reported a position in MGNX in Q1 2014 and held it in 19 quarters. The position peaked at $21.2M in Q1 2021. 134 funds tracked by Wall St. Rank hold MGNX as of Q3 2022.

  • Opaleye Management reported no remaining MacroGenics position as of Q3 2022 after selling out during the quarter.
  • Opaleye Management sold 208,300 MacroGenics shares in Q3 2022, an estimated $614K.
  • Opaleye Management first reported a position in MacroGenics in Q1 2014 and held it in 19 quarters.
  • Opaleye Management's MacroGenics position peaked at $21.2M in Q1 2021.
  • 134 funds tracked by Wall St. Rank held MacroGenics as of Q3 2022.

Based on Opaleye Management's 13F filing for Q3 2022, filed 14 Nov 2022.